---
layout: post
title: "Clee Medical wins CHF 150,000 to develop next-generation neurosurgical technology."
date: 2025-03-01
background: '/img/posts/02.jpg'
---

<p>We are excited to announce that one of our spin-offs, <strong>Clee Medical SA</strong>, has won the third stage of the Venture Kick program—an initiative that supports the development of high-potential businesses in Switzerland! 🎉 The start-up has secured CHF 150,000 to further its groundbreaking <strong>#neurosurgical technology</strong>.</p>

<p>By combining advanced imaging with <strong>#AI-assisted guidance</strong>, Clee Medical is addressing key challenges in neurosurgery—enhancing visualization, reducing surgical risks, and expanding treatment possibilities. Their innovative <strong>#technology</strong> seamlessly integrates into existing workflows, offering 300,000 more voxels per unit volume than MRI—without contrast agents or radiation.</p>

<p>👏 We are thrilled to see <strong>#CleeMedical</strong>'s work recognized for bringing next-generation technology to neurosurgeons, advancing precision, and ultimately improving patient outcomes.</p>

<p>For more updates, please check out our <a href="https://www.linkedin.com/posts/wyss-center-for-bio-and-neuroengineering_neurosurgical-ai-technology-activity-7310962792293957633-iD7d?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAt6QMBkz0zp24Bf0IhzwTDrW4y95zRpXE" target="_blank">LinkedIn post</a>.</p>
